Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.

Sutton LM, Warmuth MA, Petros WP, Winer EP.

Cancer Chemother Pharmacol. 1997;40(4):335-41.

PMID:
9225952
2.

A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.

Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, Hofacker J, Branch RA.

Cancer Chemother Pharmacol. 1997;39(4):349-56.

PMID:
9025776
3.

Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.

Toma S, Raffo P, Nicolo G, Canavese G, Margallo E, Vecchio C, Dastoli G, Iacona I, Regazzi-Bonora M.

Int J Oncol. 2000 Nov;17(5):991-1000.

PMID:
11029503
4.

Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.

Budd GT, Adamson PC, Gupta M, Homayoun P, Sandstrom SK, Murphy RF, McLain D, Tuason L, Peereboom D, Bukowski RM, Ganapathi R.

Clin Cancer Res. 1998 Mar;4(3):635-42.

5.

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, Egorin MJ, Sridhara R, Finley R, Hemady R, Wu S, Tait NS, Van Echo DA.

Cancer Chemother Pharmacol. 1997;39(4):291-9.

PMID:
9025769
6.

Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.

Park SH, Gray WC, Hernandez I, Jacobs M, Ord RA, Sutharalingam M, Smith RG, Van Echo DA, Wu S, Conley BA.

Clin Cancer Res. 2000 Mar;6(3):847-54.

7.

Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.

Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF, Balis FM.

J Clin Oncol. 1997 Nov;15(11):3330-7.

PMID:
9363862
8.

All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase.

Russo D, Regazzi M, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Iacona I, Candoni A, Grattoni R, Galieni P, Rupoli S, Liberati AM, Maiolo AT.

Leukemia. 1998 Apr;12(4):449-54.

PMID:
9557600
9.
10.

Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.

Lawrence JA, Adamson PC, Caruso R, Chow C, Kleiner D, Murphy RF, Venzon DJ, Shovlin M, Noone M, Merino M, Cowan KH, Kaiser M, O'Shaughnessy J, Zujewski J.

J Clin Oncol. 2001 May 15;19(10):2754-63.

PMID:
11352969
11.

Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.

Toffoli G, Sorio R, Aita P, Crivellari D, Corona G, Bearz A, Robieux I, Colussi AM, Stocco F, Boiocchi M.

Clin Cancer Res. 2000 Jun;6(6):2279-87.

12.

Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.

Ozpolat B, Lopez-Berestein G, Adamson P, Fu CJ, Williams AH.

J Pharm Pharm Sci. 2003 May-Aug;6(2):292-301.

13.

4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.

Takitani K, Tamai H, Morinobu T, Kawamura N, Miyake M, Fujimoto T, Mino M.

J Nutr Sci Vitaminol (Tokyo). 1995 Aug;41(4):493-8.

PMID:
8676222
16.
17.

[Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].

Chen G, Shen Z, Zhu AP.

Zhonghua Nei Ke Za Zhi. 1997 May;36(5):295-9. Chinese.

PMID:
10374268
18.

Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Chen GQ, Shen ZX, Wu F, Han JY, Miao JM, Zhong HJ, Li XS, Zhao JQ, Zhu J, Fang ZW, Chen SJ, Chen Z, Wang ZY.

Leukemia. 1996 May;10(5):825-8.

PMID:
8656678
19.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E 3rd, Ayash L.

Bone Marrow Transplant. 2001 Feb;27(3):269-78.

20.

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.

Estey E, Thall PF, Mehta K, Rosenblum M, Brewer T Jr, Simmons V, Cabanillas F, Kurzrock R, Lopez-Berestein G.

Blood. 1996 May 1;87(9):3650-4.

Supplemental Content

Support Center